The efficacy and safety of accelerated repetitive transcranial magnetic stimulation (rTMS) compared with conventional rTMS in major depressive disorder: active treatment controlled, randomized, non-inferiority study

Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 30 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•Patients taking two or less antidepressant medications without change of dosage within two weeks
•- Illness duation is less than 5 years
•- Montgomery-Asberg Depression Rating Scale score is equal to or higher than 22

•- Patient who has other Axis I disoder including schizophrenia, bipolar disorder and so on.
•- Patient who has been treated with rTMS or electroconvulsive therapy.
•- Past history of seizure disorder
•- 1st degree family history of seizure disorder
•- Substance dependence or other medical illnesses which have significant effect on brain function
•- Organic brain disease such as brain tumor or intracranial hemorrhage
•- Patients who have taken medication lowering seizure threshold (ex: theophylline)
•- Patients who have artificial metal in the body (cochlear implantation or pacemaker)
•- Clinically inappropriate patient for rTMS

发起方

Yonsei University Health System, Gangnam Severance Hospital